Skip to main content

Advertisement

Log in

Anti-CCP status determines the power Doppler oscillation pattern in rheumatoid arthritis: a prospective study

  • Imaging
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory disease leading to joint destruction. Serologically, it can be differentiated according to rheumatoid factor (RF), anti-cyclic citrullinated peptide antibodies (anti-CCP), or both. This differentiation is prognostically and therapeutically relevant. No method has been described to separate the two forms phenotypically. We hypothesize that a differentiation is possible by evaluating oscillation patterns in power Doppler sonography (PDS). In a prospective study, 20 patients with anti-CCP-positive RA and 20 patients with anti-CCP-negative RA with active wrist synovitis were examined. A PDS scan was performed, and perfusion maxima (P max) and minima (P min) as well as the amplitude (ΔP) were determined by a blinded study member. The amplitude was standardized (sΔP) by dividing by P max, and the anti-CCP-positive and anti-CCP-negative patients as well as the RF-positive and RF-negative were compared to each other. In the ultrasonographic evaluation, we found a highly significant difference in sΔP between CCPp and CCPn patients (median 19.0 vs. 42.9 %, p < 0.0001). sΔP is independent of disease activity. The absolute amplitude ΔP did not differ between the groups. Also, in anti-CCP-positive patients there was a completely linear correlation between P max and P min, and this was far less marked in anti-CCP-negative patients. Anti-CCP-positive and anti-CCP-negative RA display different PDS oscillation patterns. This constitutes a nonserological parameter to differentiate between the two forms. The difference in PDS oscillation patterns suggests that the underlying pathological process differs between the forms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Hawker G et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against rheumatism collaborative initiative. Arthritis Rheum 69:1580e8

    Google Scholar 

  2. Van Venrooij W, Zendman A (2008) Anti-CCP2 antibodies: an overview and perspective of the diagnostic abilities of this serological marker for early rheumatoid arthritis. Clinic Rev Allergy Immunol 34:36–39

    Article  Google Scholar 

  3. Bukhari M, Thomson W, Naseem H, Bunn D, Silman A, Barton A et al (2007) The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk Arthritis Register. Arthritis Rheum 56:2929–2935

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Isaacs JD, Cohen SB, Emery P, Tak PP, Wang J, Read SJ et al (2013) Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis. Ann Rheum Dis 72:329–336

    Article  CAS  PubMed  Google Scholar 

  5. Van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Huizinga TW, Toes RE, de Vries RR (2006) The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 54:1117–1121

    Article  CAS  PubMed  Google Scholar 

  6. Verpoort KN, van Gaalen FA, Van der Helm-van Mil AH, Schreuder GM, Breedveld FC, Toes RE et al (2005) Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis. Arthritis Rheum 52:3058–3062

    Article  CAS  PubMed  Google Scholar 

  7. Terao C, Yamakawa N, Yano K, Markusse IM, Ikari K, Matsuda F et al (2015) Rheumatoid factor is associated with the distribution of hand joint destruction in rheumatoid arthritis. Arthritis Rheum 67:3113–3123

    Article  CAS  Google Scholar 

  8. Ohmdorf S, Backhaus M (2015) Pro musculoskeletal ultrasonography in rheumatoid arthritis. Clin Exp Rheumatol 33(Suppl. 92):50–53

    Google Scholar 

  9. Szkudlarek M, Court-Payen M, Jacobsen S, Klarlund M, Thomsen HS, Østergaard M (2003) Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis. Arthritis Rheum 48:955–962

    Article  PubMed  Google Scholar 

  10. Schmidt WA, Schönau V, Reiche BE, Oberdorfer PE, Ohmdorf S, Backhaus M (2015) Grading of ultrasound Doppler signals in synovitis: Does it need an update? Rheumatology 54:1897–1903

    Article  PubMed  Google Scholar 

  11. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324

    Article  CAS  PubMed  Google Scholar 

  12. Hau M, Kneitz C, Tony HP, Keberle M, Jahns R, Jenett M (2002) High resolution ultrasound detects a decrease in pannus vascularisation of small finger joints in patients with rheumatoid arthritis receiving treatment with soluble tumour necrosis factor alpha receptor (etanercept). Ann Rheum Dis 61:55–58

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Schueller-Weidekamm C, Krestan C, Schueller G, Kapral T, Aletaha D, Kainberger F (2007) Power Doppler sonography and pulse-inversion harmonic imaging in evaluation of rheumatoid arthritis synovitis. AJR Am J Roentgenol 188:504–508

    Article  PubMed  Google Scholar 

  14. Litwin SD, Singer JM (1965) Studies of the incidence and significance of anti gamma globulin factors in the aging. Arthritis Rheum 8:538–550

    Article  CAS  PubMed  Google Scholar 

  15. Kelly S, Bombardieri M, Humby F, Ng N, Marelli A, Pitzalis C et al (2015) Angiogenic gene expression and vascular density are reflected in ultrasonographic features of synovitis in early rheumatoid arthritis: an observational study. Arthritis Res Ther 17:58

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

No external funding was obtained for performing this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ottar Gadeholt.

Ethics declarations

Conflict of interest

Ottar Gadeholt, Tobias Wech, Sebastian Schuh, Eva Ostermeier, Eva Christina Scharbatke and Marc Schmalzing declare that they have no conflict of interest. Hans-Peter Tony: Consultant/speaker buro: Abbvie, BMS, Chugai, Janssen, Lilly, MSD, Novartis, Roche, Takeda, UCB.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (AVI 780 kb)

Supplementary material 2 (AVI 952 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gadeholt, O., Wech, T., Schuh, S. et al. Anti-CCP status determines the power Doppler oscillation pattern in rheumatoid arthritis: a prospective study. Rheumatol Int 36, 1671–1675 (2016). https://doi.org/10.1007/s00296-016-3548-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-016-3548-6

Keywords

Navigation